What the Federal Psychedelics Executive Order Actually Does (and Doesn’t Do)
The definitive read on the Executive Order on psychedelic therapies signed on April 18th, 2026 by Delphi and the Ibogaine Healthcare Policy Institute (IHPI).
The definitive read on the Executive Order on psychedelic therapies signed on April 18th, 2026 by Delphi and the Ibogaine Healthcare Policy Institute (IHPI).
This month, the strongest policy signal is that access is being built from multiple directions at once. Texas is using state dollars to stand up an ibogaine clinical trial consortium, federal lawmakers are trying to unlock a pre-approval access pathway for Schedule I psychedelics, and health systems abroad are moving from “permission” to “payment” with tighter delivery rules.
Psychedelic Policy News from November 2025 where we cover veterans getting access, faster psilocybin approval, and micro(dosing) results.